Počet záznamov: 1
ranibizumab
SYS d000069579 LBL 00000nx^^^2200181-^^45^^ 005 20240119200759.6 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a ranibizumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2016 (2005) $8 eng 330 1-
$a A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION. $8 eng 450 $a RhuFab V2 $5 e $8 slo 550 $3 sllk_un_auth*d042461 $Y Vascular Endothelial Growth Factor A $5 F $a faktor A, rastový endotelový vaskulárny 686 $a D12.776.124.486.485.114.224.060.868 686 $a D12.776.124.790.651.114.224.060.868 686 $a D12.776.377.715.548.114.224.200.868 750 $a Ranibizumab $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160209 801 -2
$a SK $b BA006 $c 20220930 980 $x M
Počet záznamov: 1